Bristol-Myers Squibb's (NYSE:BMY) Buy Rating Reaffirmed at Jefferies Group LLC

Frederick Owens
August 12, 2017

William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will post earnings per share of $0.75 for the quarter, up from their previous forecast of $0.71. 171.98 million shares or 0.64% less from 173.08 million shares in 2016Q3 were reported. With 2.69 million avg volume, 5 days are for CA Incorporated (NASDAQ:CA)'s short sellers to cover CA's short positions. The SI to Genpact Limited's float is 8.78%. It closed at $121.07 lastly. Southern Co (NYSE:SO) has risen 2.49% since August 11, 2016 and is uptrending. It has underperformed by 16.38% the S&P500. The value of the investment in BMY went from $5,918,000 to $6,131,000 increasing 3.6% quarter over quarter. Tradewinds Capital Management LLC now owns 1,945 shares of the biopharmaceutical company's stock worth $108,000 after buying an additional 500 shares during the last quarter. Bristol Myers Squibb Co now has $92.80B valuation. The firm owned 51,770 shares of the biopharmaceutical company's stock after buying an additional 770 shares during the period. The company's stock had a trading volume of 4,060,530 shares. The company also recently announced a dividend for shareholders paid on Tuesday August 1st, 2017. It has underperformed by 18.19% the S&P500. A statistical measure of the dispersion of returns (volatility) for BMY producing salvation in Investors mouth, it has week volatility of 1.65% and for the month booked as 1.84%. Its down 0.16, from 1.13 in 2016Q3. 39 funds opened positions while 62 raised stakes. Northern Trust Corp now owns 24,041,862 shares of the biopharmaceutical company's stock valued at $1,339,612,000 after buying an additional 910,496 shares in the last quarter. Btr Capital Management Inc owns 3,853 shares for 0.05% of their portfolio. Parametric Portfolio Associate Ltd Liability Corporation owns 3.21M shares. Howland Capital Mngmt Ltd Llc accumulated 42,368 shares or 0.23% of the stock.

WARNING: "Nippon Life Global Investors Americas Inc". (NASDAQ:CA) for 11,252 shares. Cullen Frost Bankers holds 394,952 shares or 0.79% of its portfolio. Fiduciary Trust owns 98,230 shares. The return on assets ratio shows how well management is employing the company's total assets to make a profit. (NASDAQ:CA). Teachers Insurance And Annuity Association Of America holds 0.28% or 259,400 shares. Bogle Limited Partnership De reported 217,433 shares. Glenmede Tru Na has invested 0.02% of its portfolio in Genpact Limited (NYSE:G). Following the completion of the acquisition, the director now owns 18,000 shares of the company's stock, valued at approximately $1,006,920. Blackrock Japan Ltd accumulated 407,519 shares. Macquarie Group Incorporated Ltd holds 0.05% or 410,956 shares in its portfolio. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Therefore 17% are positive.

Among 6 analysts covering Intelsat S.A. Mizuho upgraded CA, Inc. UBS has "Buy" rating and $80 target. The stock of Unilever plc (ADR) (NYSE:UL) earned "Outperform" rating by Bernstein on Monday, August 22. The stock of CA, Inc. On Friday, September 9 the stock rating was maintained by Barclays Capital with "Equal-Weight". The rating was maintained by Leerink Swann on Thursday, July 27 with "Buy". Cowen & Co has "Sell" rating and $3000 target. The firm earned "Hold" rating on Friday, July 14 by RBC Capital Markets. Jefferies maintained CA, Inc. $1.21 million worth of Southwest Airlines Co (NYSE:LUV) was sold by Lamb Jeff on Thursday, May 25. As per Wednesday, April 19, the company rating was maintained by Jefferies.

CA, engaged in providing software solutions enabling clients to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The Firm operates through three business divisions: Mainframe Solutions, Enterprise Solutions and Services. It has a 423.99 P/E ratio. The Company's divisions include Business process outsourcing and Information technology services.

More news: Can Chelsea repeat as Premier League champions?

Since May 11, 2017, it had 1 insider purchase, and 3 sales for $3.06 million activity. About shares traded. Bio-Rad Laboratories, Inc. Therefore 7% are positive. BMO Capital Markets cut Bristol-Myers Squibb from a "market perform" rating to an "underperform" rating and set a $47.00 price target for the a research report on Wednesday, May 3rd. A buy rating from an analyst or research firm is a recommendation to purchase the security, with the implied insistence that the security is undervalued in some fashion. The rating was maintained by SunTrust with "Neutral" on Monday, October 19. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned "Buy" rating by Guggenheim on Wednesday, December 2. To conclude comes the ratings part in which the company was evaluated with "10" Analysts of WSJ going for Buy ratings in current phase, while at present "1" Analyst gave Overweight ratings from whole pool. ANDREOTTI LAMBERTO sold $1.81 million worth of Bristol-Myers Squibb Co (NYSE:BMY) on Thursday, April 6. Jefferies has "Hold" rating and $59 target. As per Thursday, August 3, the company rating was initiated by Wedbush. The firm has "Hold" rating given on Tuesday, March 15 by Jefferies. The company was maintained on Friday, August 19 by UBS. About 1.03M shares traded. Schmukler Louis S sold 5,000 shares worth $282,470.

Shares of Bristol-Myers Squibb (NYSE:BMY) traded up 0.25% on Wednesday, hitting $56.73. 12,000 shares valued at $681,240 were bought by Samuels Theodore R. II on Monday, February 27.

Investors sentiment decreased to 0.83 in 2016 Q4. Its down 0.23, from 0.9 in 2016Q3. It dived, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. Marshall Wace Limited Liability Partnership reported 220,295 shares or 0.23% of all its holdings.

Other reports by LeisureTravelAid

Discuss This Article